PTSD Trial, Recruiting NCT04180930 Sponsor: U.S. Army Medical Research and Development Command Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT04180930
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are currently serving in the military or are military veterans, aged 18 or older
  • People who are able to understand and agree to participate in the study on their own
  • People who have experienced at least one seriously distressing or traumatic event (such as those listed on a standardised trauma checklist called the LEC-5)
  • People who score 3 or above on a short standard screening questionnaire for post-traumatic stress symptoms (called the PC-PTSD-5)

Who may not be able to join:

  • People who are currently having thoughts of suicide or harming others with a specific plan, or who have a substance use problem that requires medical detox either now or within the past month
  • People who have completed a specific PTSD assessment tool (called the CAPS or PSSI) within the past year
  • People who are currently receiving any therapy or counselling specifically for PTSD
  • People with moderate to severe difficulties with memory or thinking, as measured by a standard cognitive assessment tool called the MoCA
  • People who, in the past month, have had a diagnosis of Bipolar I, Bipolar II, Schizophrenia, or another psychotic disorder that is not currently being treated with medication

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kathleen M Chard, PhD, Cincinnati VA Medical Center, University of Cincinnati

Phone: 513-861-3100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
U.S. Army Medical Research and Development Command
Registry
ClinicalTrials.gov
Start date
15 April 2019
Est. completion
30 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Test-Retest reliability of Clinician Administered PTSD Scale for DSM-5 (CAPS-5) Total Score; Test-retest reliability of PTSD Symptom Scale - Interview for DSM-5 (PSSI-5) Total Score; Correlation among the total scores of the CAPS-5, PSSI-5, and Clinician Administered PTSD Scale for DSM-IV (CAPS-IV); Stability of the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) item-level scores over 6 weeks; Stability of PTSD Symptom Scale - Interview for DSM-5 (PSSI-5) item-level scores over 6 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov